Resource type: Information leaflet
Publication type: Stroke information
Occupational therapy can help you adjust to life after stroke by giving you the confidence and skills to perform daily tasks. This guide explains what to expect from occupational therapy and how you can find an occupational therapist.
Browse through a list of organisations that can provide support and information on treatment and therapy options.
The Douglas Drive Speech Tharapy Group welcomes membership from people affected by stroke in and around the Stevanage area. The group provides peer and communication support and offers social and recreational activities including games, conversation, outings, talks and presentations by visiting speakers.
What maintains stroke survivors’ continued use of self-managed computer therapy for aphasia?
Calling all speech and language therapists who see people with progressive aphasia to support new research into speech and language therapy practices for this group.
Thousands of stroke survivors with visual problems could improve their sight from the comfort of their own home using two new web-based therapies.
This study will explore whether an existing therapy, Solution Focused Brief Therapy (SFBT), can be used for people with aphasia. Information will also be collected to design a future large-scale trial evaluating this approach.
This project aims to develop and test a repetitive functional task practice (RFTP) therapy programme. Research physiotherapists will develop the programme in conjunction with stroke unit staff and patients.
Published in the JNNP (Journal of Neurology, Neurosurgery and Psychiatry), new research suggests that a computer technique could help predict how well stroke survivors respond to language therapies for aphasia.
Funded by the European Union (EU), a new international study called PROOF will investigate whether high-dose oxygen therapy can reduce the effects of stroke.
The Stroke Association is a member of the Stroke Alliance For Europe (SAFE), which will work on communication of information about the PROOF trial to non-clinical audiences.